期刊
EXPERT REVIEW OF VACCINES
卷 12, 期 10, 页码 1139-1154出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2013.836914
关键词
attenuation; cancer vaccine; danger signal; listeriolysin; Listeria monocytogenes; live bacteria; Pseudomonas aeruginosa; Salmonella typhimurium; type 3 secretion system
类别
In the emerging field of active and specific cancer immunotherapy, strategies using live-attenuated bacterial vectors have matured in terms of academic and industrial development. Different bacterial species can be genetically engineered to deliver antigen to APCs with strong adjuvant effects due to their microbial origin. Proteic or DNA-encoding antigen delivery routes and natural bacterial tropisms might differ among species, permitting different applications. After many academic efforts to resolve safety and efficacy issues, some firms have recently engaged clinical trials with live Listeria or Salmonella spp. We describe here the main technological advances that allowed bacteria to become one of the most promising vectors in cancer immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据